We spoke with Mark Boothby, Professor of Immunology at Vanderbilt University, about his experience publishing with eLife.

Published and presented the full safety and efficacy data for the Phase 1/2 trial, as well as new immunology data demonstrating the ability of INO-3107 to induce antigen-specific T cell responses ...

Operator Good afternoon, ladies and gentlemen, and welcome to the INOVIO Pharmaceuticals fourth quarter 2024 financial ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

The integration of single-cell technologies with computational techniques marks the dawn of a new era in therapeutic discovery, enabling unprecedented ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.

A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

US research has been under political pressure for some time. Examples include regulatory overreach on federal stem-cell research informed more by religion than scientific arguments, a growing vaccine ...